Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: J Clin Oncol. 2006 Oct 1;24(28):4603–4610. doi: 10.1200/JCO.2005.04.5518

Table 3.

Pairwise Correlations Among MRI and Pathology or Immunohistochemistry Features

Pathology Variables
Immunohistochemistry Variables
MRI Variable Size Density Nuclear Grade Comedo Ki67 CD68 CD34 ER Score
Size
r 0.55 0.20 0.15 0.23 0.00 0.40 −0.20 −0.20
P .0001* .1823 .3284 .1264 .9747 .0061* .1946 .1852
% of breast involved
r 0.52 0.32 0.12 0.21 −0.06 0.46 −0.18 −0.16
P .0003* .0315* .4396 .1654 .6843 .0014* .2484 .3009
Density
r 0.12 0.45 −0.13 0.25 −0.12 0.47 −0.23 −0.06
P .4204 .0021* .4126 .0927 .435 .0012* .1275 .7097
Enhancement pattern
r −0.19 −0.37 −0.18 −0.20 −0.03 −0.15 0.09 0.01
P .2187 .0122* .2474 .1867 .8602 .3341 .5709 .9643

Abbreviations: MRI, magnetic resonance imaging; ER, estrogen receptor.

*

P < .05.